ZA986673B - Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders - Google Patents

Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders

Info

Publication number
ZA986673B
ZA986673B ZA986673A ZA986673A ZA986673B ZA 986673 B ZA986673 B ZA 986673B ZA 986673 A ZA986673 A ZA 986673A ZA 986673 A ZA986673 A ZA 986673A ZA 986673 B ZA986673 B ZA 986673B
Authority
ZA
South Africa
Prior art keywords
diuretic
combination
converting enzyme
inhibitor
microcirculatory disorders
Prior art date
Application number
ZA986673A
Other languages
English (en)
Inventor
David Guez
Pierre Schiavi
Bernard Levy
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA986673B publication Critical patent/ZA986673B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA986673A 1997-11-19 1998-07-27 Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders ZA986673B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714485A FR2771010B1 (fr) 1997-11-19 1997-11-19 Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires

Publications (1)

Publication Number Publication Date
ZA986673B true ZA986673B (en) 1999-02-04

Family

ID=9513523

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986673A ZA986673B (en) 1997-11-19 1998-07-27 Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders

Country Status (21)

Country Link
US (1) US6653336B1 (hu)
EP (1) EP1032414B1 (hu)
JP (1) JP2001523646A (hu)
CN (1) CN1227029C (hu)
AT (1) ATE239500T1 (hu)
AU (1) AU740748B2 (hu)
BR (1) BR9814885A (hu)
CA (1) CA2310136C (hu)
DE (1) DE69814444T2 (hu)
DK (1) DK1032414T3 (hu)
EA (1) EA002968B1 (hu)
ES (1) ES2198708T3 (hu)
FR (1) FR2771010B1 (hu)
HK (1) HK1033096A1 (hu)
HU (1) HU226022B1 (hu)
NO (1) NO20002479L (hu)
NZ (1) NZ504220A (hu)
PL (1) PL340561A1 (hu)
PT (1) PT1032414E (hu)
WO (1) WO1999025374A1 (hu)
ZA (1) ZA986673B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
AU2002303840A1 (en) * 2001-05-31 2002-12-09 Microdose Technologies, Inc. Metering and packaging of controlled release medication
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril
WO2005021039A1 (en) * 2003-08-29 2005-03-10 Cotherix, Inc. Combination of cicletanine and an oral antidiabetic and/or blood lipid-lowering agent for treating diabetes and metabolic syndrome
CN1292747C (zh) * 2003-09-16 2007-01-03 广东省心血管病研究所 一种用于治疗高血压的复方制剂
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
WO2005094793A1 (en) * 2004-03-29 2005-10-13 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing a solid pharmaceutical composition
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
WO2008068577A2 (en) * 2006-12-01 2008-06-12 Glenmark Pharmaceuticals Limited Pharmaceutical compositions
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CN107496899A (zh) 2011-09-29 2017-12-22 梅约医学教育与研究基金会 芳族阳离子肽和使用它们的方法
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CA3126333A1 (en) * 2019-01-09 2020-07-16 Ken-ichi YAMADA Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
PT804229E (pt) * 1995-03-16 2003-06-30 Pfizer Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica

Also Published As

Publication number Publication date
PL340561A1 (en) 2001-02-12
EA002968B1 (ru) 2002-12-26
WO1999025374A1 (fr) 1999-05-27
HUP0004544A3 (en) 2001-07-30
DK1032414T3 (da) 2003-09-01
NO20002479D0 (no) 2000-05-12
HU226022B1 (en) 2008-03-28
DE69814444T2 (de) 2004-03-18
PT1032414E (pt) 2003-08-29
HUP0004544A2 (hu) 2001-06-28
AU740748B2 (en) 2001-11-15
ES2198708T3 (es) 2004-02-01
EA200000536A1 (ru) 2000-10-30
NZ504220A (en) 2003-05-30
BR9814885A (pt) 2000-10-03
US6653336B1 (en) 2003-11-25
FR2771010B1 (fr) 2003-08-15
DE69814444D1 (de) 2003-06-12
NO20002479L (no) 2000-05-12
EP1032414B1 (fr) 2003-05-07
HK1033096A1 (en) 2001-08-17
FR2771010A1 (fr) 1999-05-21
AU6837798A (en) 1999-06-07
CA2310136C (fr) 2004-04-20
EP1032414A1 (fr) 2000-09-06
CN1227029C (zh) 2005-11-16
ATE239500T1 (de) 2003-05-15
JP2001523646A (ja) 2001-11-27
CN1279615A (zh) 2001-01-10
CA2310136A1 (fr) 1999-05-27

Similar Documents

Publication Publication Date Title
ZA986673B (en) Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
BG104780A (en) Inhibitors of phospholipase enzymes
AU688952B2 (en) Thrombin inhibitors
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
ZA951974B (en) Bradykinin antagonist peptides incorporating N-subsituted glycines
EP0646007A1 (en) NEW DELTA-17 AND DELTA-20 UNSATURATED AND SATURATED 17 - g (b) -SUBSTITUTED-4-AZA-5-g (a) -ANDROSTAN-3-ON COMPOUNDS AS INHIBITORS OF 5-ALPHA REDUCTASE.
NZ330451A (hu)
AU8011194A (en) Compounds, compositions and treatment of allergies and inflammation
AU7957894A (en) Compounds, compositions and treatment of allergies and inflammation therewith
BG102814A (en) New derivatives of carboxylic acid, their preparation and application
MX9801190A (es) Inhibidores de prolil endopeptidasa.
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
IL112423A0 (en) Inhibitors of serine proteases, their preparation and pharmaceutical compositions containing them
AU6849198A (en) Neurotrypsin
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
ZA9711468B (en) New use of comt inhibitors
BG100686A (en) Use of dimeticone for treating constipation
BG104373A (en) Polymorphous forms of dofetilide
AU5994696A (en) Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues